Atriva Therapeutics
Germany - PlaneggBiotechnology
Focus: Atriva Therapeutics is a German biotech focused on developing inhibitors against respiratory viral infections, particularly influenza. The company operates as a pre-revenue stage biotech with early-stage clinical programs.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Atriva Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Atriva Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ATR-002
InfluenzaClinical Trials (3)
NCT04776044Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19
Phase 2Help build intelligence for Atriva Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.